Recognizing Risk and Benefits of Management Options for Aplastic Anemia
This case examines the treatment approaches for aplastic anemia, including immunosuppressant therapy (IST), hematopoietic stem cell transplantation (HSCT), and supportive care. It explores appropriate patient selection based on etiology and other considerations (eg, severity of disease, patient age, etc).
This site uses cookies. By continuing to use this website, you agree to their use. For details, please check our Privacy Policy.